The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study
NCT ID: NCT00894946
Last Updated: 2009-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
350 participants
INTERVENTIONAL
2009-05-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endometrial Effects of Lipiodol
NCT03542331
The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.
NCT01682642
Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure
NCT01800513
Endometrial Injury for Assisted Reproduction
NCT01132144
Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis
NCT03940807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recurrent IVF implantation failure
Lipiodol + IVF
IVF preceded by lipiodol
IVF
IVF alone
Endometriosis
Lipiodol + IVF
IVF preceded by lipiodol
IVF
IVF alone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lipiodol + IVF
IVF preceded by lipiodol
IVF
IVF alone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 39
* Endometriosis or recurrent IVF implantation failure
* Patent fallopian tubes
Exclusion Criteria
* Blocked fallopian tube or tubes
18 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Auckland, New Zealand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Auckland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neil Johnson, MD
Role: PRINCIPAL_INVESTIGATOR
University of Auckland, New Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Auckland
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVF-LUBE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.